CannPal was founded by a team of experienced executives to establish a new standard of care in Animal Health by providing veterinarians with regulatory approved, Cannabinoid-based pharmaceuticals. We’ve identified an opportunity to develop first-in-class medicines for cats, dogs and horses, derived from the Cannabis plant, that have already shown safety and efficacy in humans and rodent studies.
Pioneers in cannabinoid animal health
Baden BowenChief Financial Officer
Baden is a Chartered Accountant with more than 30 years of experience in administration and financial management within the accounting profession and commerce. His areas of specialty include company secretarial, financial accounting and management reporting for publicly and privately held Companies.
Max JohnstonNon-Executive Director
Max has over 45 years of experience holding board positions across ASX listed companies and has senior executive experience in market leading corporate companies such as Unilever, United Distillers and Johnson & Johnson Pacific where he acted as Managing Director.
Dr Kate AdamsNon-Executive Director
Dr Kate Adams has held a number of government advisory and analyst roles in her career along with private company experience as the Director of Science, Technology and Intellectual Property at Palladion Partners. Kate is also a practicing Veterinarian and part owner of Bondi Veterinary Hospital.
Mara GordonMedical Cannabis Adviser
Mara is a Cannabinoid expert and founder of Aunt Zelda's, Calla Spring Wellness, and Zelda Therapeutics. Mara specializes in the development of treatment protocols utilizing Bio Pharmaceutical grade cannabis extracts for seriously ill patients in California, where she currently resides.
Dr Ted WhittemCommercial Veterinary Adviser
Dr Ted Whittem is the current Head of the Melbourne Veterinary School, and a highly experienced Veterinary Pharmacologist. Dr Whittem has also worked as a senior executive in veterinary pharmaceuticals where he brought more than 30 products to the market.
Amanda ReimanCannabis Regulatory Adviser
Amanda Reiman was the Manager of Marijuana Law and Policy at the Drug Policy Alliance in California, where she worked to develop DPA’s marijuana reform work relating to litigation, legislative drafting, campaign strategy and policy advocacy in state, federal, and international jurisdictions.